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1. Introduction
Consumer use of wearable devices has become an increasingly strong trend over recent years [1]. According to statistics, approximately 225 million wearable devices were
purchased by users worldwide in 2019 [2], rising at a compound annual growth (CAGR)
of approximately 13% from 2020 to 2027 [3]. Moreover, published reports confirm that
most adults in Canada [4] and Australia [5] use wearable devices. Besides, as reported by
Statista, the penetration rate of wearable devices among American adults is expected to
reach over 25% by 2022 [6], which shows the high popularity of these devices worldwide.
Among the most popular wearable devices are the Apple Watch, Fitbit and Garmin.
Apple Watch alone accounted for 49% of the global smartwatch market in 2016. Moreover,
Apple Watch had a share of more than 33% of the smartwatch market in 2021 [7]. Among
the various brands of wearable devices is Fitbit, which was founded in 2007 and presently
is officially part of Google company. The sale of more than 120 million devices since 2009

(https://creativecommons.org/licenses/
by/4.0/).
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in over 100 countries indicates the acceptance and widespread use of Fitbit worldwide [8].
Founded in Kansas in 1989, Garmin has been making activity trackers since 2006, and
became the fifth largest exporter of activity trackers in the world in 2018, with a market
share of more than 5% [9].
The widespread public interest in wearable devices, especially smartwatches, has
provided a new opportunity for both consumers and healthcare systems for remote and
continuous monitoring, and tracking health endpoints are used as an intervention and
measurement devices in clinical settings.
Tracking individuals' physical activity for assessing step counts, heart rate [10], and
other parameters as an intervention [11–13] as well as in conjunction with other treatments
[14, 15] has resulted in changing the population’s physical behavior and in revolutionizing
medical decision making [16]. In addition, smartwatches, specifically Fitbit, account for
89% of published papers, 83% of clinical trials, and 95% of NIH-funded research in biomedical studies [17]. Also, conducting a search in the clinical trial electronic database on
the 25th of August 2021 yielded 704 clinical Fitbit, Garmin, or Apple watch-based studies.
Despite the rising popularity of commercial smartwatches, especially in recent years,
there is still uncertainty about their validity and accuracy in evaluating measures related
to physical activity [1]. In other words, the existing evidence for the efficiency of trackerbased interventions is indecisive [18]. For example, in a systematic review study, synthesis
of the evidence showed that Fitbit did not provide an accurate measure of the amount of
energy expended in each test condition [19]. Therefore, incorrect estimation of clinical data
can have a negative impact on medical decision making, leading to adverse outcomes.
A growing number of systematic reviews have been published on the clinical effectiveness of smart watches, but the results have been conflicting [20, 21] and need to be
studied further. The inconsistent results from current systematic reviews call for a more
systematic assessment of the strength and quality of evidence regarding the health outcomes of smartwatch-based interventions (Fitbit, Garmin, Apple Watch). Therefore, an
overview of systematic reviews has been conducted in this study to assess the current
quality of evidence in the field. It is evident that a lack of assessing the quality of evidence
in systematic reviews can lead to prejudiced treatment guidelines, negatively affecting
medical decision-making and imposing major financial burdens on healthcare systems [22].
Various instruments have been introduced to assess the quality of evidence [23], of
which the GRADE – Grading of Recommendations, Assessment, Development and Evaluations [24] has universal validity and acceptance and has been adopted by the World
Health Organization (WHO) and is recommended in the Cochrane handbook [25].
GRADE categorizes the quality of evidence into four levels including high, moderate, low,
and very low. High quality signifies that additional research is improbable to change certainty in the effect estimate, while, very low one indicates that there is very little certainty
in the effect estimate [24]. Therefore, in this study, the intention was to assess the overall
strength of evidence of systematic reviews that explain a quantitative synthesis of the impact of Fitbit, Garmin, or Apple Watch on health outcomes when compared to other interventions without a Fitbit, Garmin or Apple Watch. The study provides a far-reaching
summary of the quality of the existing evidence on outcomes of interventions using Fitbit,
Garmin or Apple Watch.
Accordingly, the hypotheses of this review are as follows:
1.
Systematic reviews evaluating the clinical effectiveness of Fitbit-, Garmin-, or
Apple Watch-based interventions on human population outcomes are of high
methodological quality.
2.
Health outcomes resulting from Fitbit-, Garmin-, or Apple Watch-based interventions have high certainty of evidence.
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2. Materials and Methods
The protocol of this systematic review was registered in advance in PROSPERO (ID:
CRD42021276533). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline was followed in this study [26].
2.1. Eligibility Criteria
Full text systematic reviews originally published in English in peer-reviewed journals describing meta-analyses of all clinical outcomes of Fitbit-, Garmin-, or Apple Watch
-based interventions compared with other comparators without Fitbit, Garmin or Apple
Watch. In other words, studies examining the effect of Fitbit, Garmin, or Apple Watch on
human populations of both genders and any age group were included. This study was
not limited to a specific population, time period, clinical setting, or geography. Animalbased studies, studies of mixed interventions and the accuracy of model testing were not
eligible for this study. All meta-analyses reporting clinical outcomes resulting from a Fitbit, Garmin, or Apple Watch -based intervention were included.
2.2. Search Strategy
Systematic searches were carried out in the PubMed, Scopus, and the Web of Science
electronic databases from inception to August 2021. The search was also updated on 20
October 2021, and the reference lists of the final eligible studies were also reviewed to find
other meta-analyses. The subsequent steps were followed: keywords Fitbit OR Garmin
OR “apple watch” were searched in the title and/or abstract in PubMed and Scopus. The
mentioned search formula was performed in the Topic field in the Web of Science database. In addition, controlled vocabulary MeSH in PubMed was used while performing the
search. To identify systematic reviews, the NIH search strategy was used in PubMed [27].
In Scopus, to identify systematic reviews, the database search filters were used, and the
document types were restricted to “review”. In the Web of Science database, the document
types were also restricted to “review articles”.
2.3. Study Selection
All identified documents from the searches were managed and entered into the Microsoft Excel software. Duplicates were identified by the DOI number. If no DOI number
was available, the titles were used to recognize the duplicates. Titles and abstracts of included studies were screened independently by two reviewers according to the following
questions: is it a systematic review study? (yes/unsure; no); is it a Fitbit, Garmin, or Apple
Watch study? (yes/unsure; no). Studies for which the answers to the questions were
yes/unsure were eligible for the next screening stage (full text screening). In the next stage,
the reviewers assessed the studies according to the following questions: is this a study
published in English? (yes; no); is this a study involving humans? (yes; no); is it a metaanalysis? (yes; no); was Fitbit, Garmin, or Apple Watch used as an intervention in the
study? (yes; no). Filtering the answer to all questions by "yes" identified eligible studies.
In both the title/abstract and the full-text screening, disagreements were discussed by the
reviewers to reach consensus. The results of the screening and the selection of eligible
studies were visualized using the PRISMA flowchart [28] (Figure 1).
2.4. Data Extraction
Data extraction from the qualifying studies was performed separately by two reviewers. The reviewers discussed to reach an agreement to resolve the disparities. The following variables were extracted from the studies by the reviewers: publication year, authors’
name, first author’s country using the ISO 3166-1 code, study designs of included studies,
population, intervention, comparator, outcome(s), the total number of population in each
outcome, effect size, and confidence intervals.
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2.5. Assessment of Methodological Quality
The quality of the eligible systematic reviews was methodologically and independently
assessed by two reviewers using the AMSTAR-2 tool, which contains 16 different questions
with the answers: yes, partly yes or no [29]. Any discrepancies in the ratings of the 16 items of
the AMSTAR-2 checklist were resolved through discussion to reach consensus. The following
methodology was used to report the methodological quality of the review: qualitative responses were converted into quantitative data: 1 point for questions with answers “yes”, 0.5
point for questions with answers “partly yes”, and 0 points for questions with answers “no”.
2.6. Assessment of the Quality of Evidence
As mentioned earlier, the quality of evidence of each outcome in meta-analyses was
independently assessed by two reviewers using the GRADE tool [24], which assesses the
quality of synthesis of every outcome based on five domains: 1) risk of bias [30], 2) inconsistency [31], 3) imprecision [32], 4) publication bias [33] and 5) indirectness [34]. Depending on the severity of every domain, the GRADE tool proposes a 0, 1 or 2 downgrades.
Therefore, the following strategies were applied [35].
Risk of Bias: if less than 75% of the studies included in a meta-analysis had a low risk
of bias or if the risk of bias of the individual studies included in a meta-analysis was not
reported, 1 downgrade was considered to decide on the overall risk of bias of a metaanalysis. On the other hand, no downgrading was performed if 75% or more than 75% of
the included studies in a meta-analysis had a low risk of bias.
Inconsistency: to make a decision regarding inconsistency, the reported heterogeneity (I2) was considered in each outcome. Accordingly, 1 downgrade was assigned if the calculated heterogeneity in each outcome was reported to be at least 75%. Otherwise, no downgrade was assigned. If heterogeneity was not reported, also 1 downgrade was assigned [36].
Imprecision: following the recommendations in the GRADE Handbook [24], no
downgrade was assigned to any outcome if the pooled sample size was minimum 2000.
1 downgrade was assigned if the pooled sample size was less than 200. When the size of
the pooled sample was between 200 and 2000, confidence intervals were considered. If
confidence intervals were not narrow, 1 downgrade was assigned. Otherwise, no downgrade was considered.
Publication bias: one of the most commonly used methods to assess publication bias
in studies is the funnel plot. Due to some limitations of the funnel plot method in accurately identifying the publication bias [37,38], the strategy of Trim and Fill was used [39],
which recalculates the effect size by imputing missing studies from the analysis. If the
recalculated effect size was changed due to some missing documents, 1 downgrade was
assigned. Alternatively, no downgrade was assigned.
Indirectness: to assess indirectness in each outcome, 1 or 2 downgrades was considered if there were differences between the included studies in each outcome in terms of
intervention, population, or comparator, depending on the severity of the differences. If
the included studies were consistent with the review questions in each outcome and were
coherent with regards to population, intervention, or comparator, no downgrading was
considered [40].
Finally, the quality of every evidence was reported at four levels: 0 downgrade as
a high quality, 1–2 downgrades as a moderate quality, 3–4 downgrades as a low quality,
and 5–6 downgrades as a very low quality of synthesis [36].
3. Results
3.1. Literature Search
The literature search yielded 16, 83, and 41 entries in PubMed, Scopus, and the Web
of Science, respectively. After removing duplicates, 80 studies were eligible for title/ab-
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stract screening. Twenty-six records were excluded, of which 21 records were not considered systematic reviews, and five studies were excluded because they did not focus on
Fitbit, Garmin, or Apple Watch. Consequently, 54 studies progressed to the full-text
screening stage. One study because it was not in English, 42 records because they did not
report a meta-analysis, and 10 screened documents because they did not include Fitbit,
Garmin, or Apple Watch as an intervention did not conform to the study. Because the goal
of the current evaluation was to examine the methodological and evidence synthesis quality of meta-analyses evaluating the effect of Fitbit, Garmin, or Apple Watch as an intervention on changing human health outcomes, the accuracy of model testing studies were
not suitable for this study. For example, research that provided a meta-analysis of the
accuracy of Fitbit models in evaluating sleep was excluded [41]. Overall, one systemic
review that reported a meta-analysis of the effect of Fitbit as an intervention on population
health outcomes compared with non-Fitbit, Garmin, or Apple Watch met the inclusion
criteria and was included in the final analysis[41] (see the PRISMA flow diagram, Figure 1).

Fig. 1. PRISMA flowchart of the study selection.
3.2. Characteristics of the Included Systematic Reviews
The characteristics of the included systematic review (SR) that met the inclusion criteria are summarized in Table 1. The review was published in 2020 [42]. The number of
included primary studies in the review was 41 documents. The study included healthy
subjects, patients with cardiovascular risks, cardiometabolic or chronic diseases, comparing the effect of Fitbit with methods without a device.
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Table 1. Characteristics of the included systematic review.
Author
(year)
Ringeval
M. et al.
(2020)

1

Country
Canada

Study
design
RCT1

Population

Intervention

Comparator

Outcome(s)

Healthy
subjects,
patients
with cardiovascular
risks,
chronic
diseases or
cardiometabolic diseases

Fitbit

Without
a device

Steps per
day, physical activity
(MVPA,
min/day),
weight (kg)

Conclusion
summary
Using Fitbit as an intervention
has the potential to
improve
a healthy
lifestyle
concerning
physical
activity
and
weight.

: RCT: Randomized controlled trial

3.3. Methodological Quality Results
The Amstar-2 assessment showed that the review had two items that did not meet
the criteria (overall score 13.5 out of 16). The methodological limitations arose from two
items: questions seven and ten. Moreover, “partial yes” was assigned to question four.
Due to the fact that there is one critical flaw [Item 7] with one non-critical weakness
[Item 10], the review was rated as “low” in the methodological quality[29]. More details
can be found in Table 2.
Table 2. Assessment of the methodological quality of review.
Study
1
Y

2
Y

3
Y

4
PY

5
Y

6
Y

7
N

8
Y

Items
9 10
Y N

11
Y

12
Y

13
Y

14
Y

15
Y

16
Y

Overall
score
13.5(L)

AMSTAR-2 Items:
1.
Did the research questions and inclusion criteria for the review include the components of PICO?
2.
Did the report of the review contain an explicit statement that the review methods were established prior
to the conduct of the review and did the report justify any significant deviations from the protocol?
3.
Did the review authors explain their selection of the study designs for inclusion in the review?
4.
Did the review authors use a comprehensive literature search strategy?
5.
Did the review authors perform study selection in duplicate?
6.
Did the review authors perform data extraction in duplicate?
7.
Did the review authors provide a list of excluded studies and justify the exclusions?
8.
Did the review authors describe the included studies in adequate detail?
9.
Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual
studies that were included in the review?
10. Did the review authors report on the sources of funding for the studies included in the review?
11. If meta-analysis was performed, did the review authors use appropriate methods for statistical combination of results?
12. If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual
studies on the results of the meta-analysis or other evidence synthesis?
13. Did the review authors account for RoB in individual studies when interpreting/ discussing the results
of the review?
14. Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review?
15. If they performed a quantitative synthesis, did the review authors carry out an adequate investigation of
publication bias (small study bias) and discuss its likely impact on the results of the review?
16. Did the review authors report any potential sources of conflict of interest, including any funding they
received for conducting the review?
17. Y: Yes. PY: partially yes. N: No. L: Low methodological quality
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3.4. GRADE Results
The qualified review included five outcomes related to the effect of Fitbit on steps
per day, physical activity, weight, objectively measured as well as self-reported sedentary
behavior in a group of healthy subjects, patients with cardiovascular risks, chronic or cardiometabolic diseases. The quality assessment of the evidence synthesis showed that no
outcome had high quality evidence (0%). Two of the outcomes (40%) had moderate-quality evidence synthesis, while the other three outcomes (60%) demonstrated low-quality
evidence, as shown in Table 3.
Table 3. GRADE evaluation results.
Interventions

Outcomes

Effect
size /
(95% confidence
intervals)

Risk of
Bias

Inconsistency

Imprecision

Publication bias

Indirectness

Overall
quality
rating

Fitbit vs
without
a device

Steps per
day

950.54
(MD)/
(475.89,
1425.18)

-1

0

-1

0

0

Moderate

Fitbit vs
without
a device

moderate
to vigorous
physical activity
(MVPA;
min/day)

6.16
(MD)/
(2.80,
9.51)

-1

0

-1

-1

0

Low

Fitbit vs
without
a device

difference
in weight
(kg)

-1.48
(MD)/
(-2.81, 0.14)

-1

0

-1

-1

0

Low

Fitbit vs
without
a device

sedentary
behaviors
(min/day)objectively
measured

-10.62
(MD)/
(-35.50,
14.27)

-1

0

-1

-1

0

Low

Fitbit vs
without
a device

sedentary
behaviors
(min/day)self reported

-0.11
(SMD)/
(-0.48,
0.26)

-1

0

0

0

0

Moderate

With respect to the step-per-day outcome, which had a moderate quality of evidence,
a total of two downgrades were assigned for risk of bias and imprecision, as at least 75%
of the included studies did not have a low risk of bias in this endpoint. All included studies did not meet the criteria for blinding of participants and personnel criteria. In addition,
because the total sample size in the synthesis ranged from 200 to 2000, the confidence
intervals (475.89, 1425.18), which were not regarded as narrow, were considered.
The physical activity outcome was graded as low-quality evidence because there was
a risk of bias in blinding participants and personnel in all included RCTs. Also, a downgrade in imprecision was assigned, as the sample size was 1073, and the confidence intervals were not narrow (2.80, 9.51). In addition, another downgrade was assigned because
the recalculated effect size was altered by the trim-and-fill method, as a missing study was
observed in the analysis. Regarding the weight outcome, three downgrades were assigned
due to risk of bias, imprecision, and publication bias. Consequently, this endpoint provides low-quality evidence. The reasons were: no blinding of participants and personnel
in the RCTs, the total number of samples (909) and wide confidence intervals (-2.81, -0.14),
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imputation of two missing studies, which changed the recalculated effect size using the
trim-and-fill method. In the case of objectively measured sedentary behavior, it also provides low-quality evidence based on risk of bias, imprecision and publication bias. No
blinding of participants and personnel, small number of pooled samples (173), imputation
of a missing study, which changed the recalculated effect size using the trim-and-fill
method. According to the results, self-reported sedentary behaviors outcome provides
moderate quality evidence. Only one downgrade was assigned to the risk of bias because
participants and staff were not blinded in the two included RCTs. There was no inconsistency in the outcomes as all measured heterogeneity values (I2) were less than 75%.
Also, no indirectness was found in the included RCTs in any outcome.
4. Discussion
In evidence-based medicine, methodological evaluation and assessment of the quality of evidence are strongly recommended before medical decision making [43, 44]. High
methodological quality systematic reviews providing high certainty are considered the
most important sources providing the highest level of evidence [45, 46] and influencing
medical decision making [47]. To the best of our knowledge, the current study is the first
to assess the methodological and evidence quality of systematic reviews providing metaanalyses of the effect of Fitbit, Garmin, or Apple Watch on people's health outcomes which
intends to reveal the methodological quality of systematic reviews to help clinicians make
better clinical decisions.
In accordance with the inclusion criteria, only one study was ultimately included in
the current review. Studies evaluating the clinical effect of Fitbit, Garmin, or Apple Watch
as an intervention on the human’s health outcomes were eligible. However, there are published systematic reviews with a qualitative data synthesis on the effects of smartwatches
on human health that are not consistent with the present inclusion criteria [13, 48, 49]. In
most meta-analyses, the above mentioned devices were used as an intervention in combination with other wearables [11, 12, 50–55], while a preliminary search on clinicalreial.gov
revealed numerous completed studies. For example, the role of Fitbit as an intervention
in knee replacement patients, hospitalized general patients, obese women, ICD patients,
predicting risk of preterm birth, as an activity tracker during chemotherapy for breast
cancer, etc., which signifies that scholars in this field should conduct more meta-analyses
to determine the current evidence. In addition, a similar search found only one study that
examined the clinical effectiveness of Garmin as a single intervention to predict outcomes
in high-risk perioperative patients, suggesting that more clinical trials need to be conducted to evaluate the clinical effectiveness of Garmin on health outcomes. Four completed studies were also identified that examined the role of the Apple Watch in cardiac
rhythm detection, electrocardiographic diagnostic performance, cardiac arrhythmia detection, and the effectiveness of the Apple Watch in reducing delayed or missed meal boluses.
Given the widespread adoption of wearables, especially smartwatches [2, 3], and the
fact that Fitbit, Garmin and Apple Watch are recognized as 3 of the top 5 fitness trackers
[56], they can play a prominent role in conducting clinical trials as an intervention to
change the health status of populations [42]. However, as mentioned earlier, most metaanalyses have evaluated the clinical effect of these devices as an intervention by combination with other wearables, indicating a gap in this area, suggesting that researchers should
conduct further clinical trials and meta-analyses on the effect of these devices as a single
intervention on the health status change in different patient groups.
As the results revealed, the included systematic review had low methodological
quality, indicating the need for quality improvement. The main reasons for this problem
arise from two criteria. The listing of omitted studies and the justification for each study's
exclusion is one of the most significant aspects to examine in the Amstar-2 tool. This deficiency is evident in most systematic reviews [57–62]. Because the listing excluded studies,
and justifying the exclusion reasons for each study is a critical domain in the methodology
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of systematic reviews according to the Amstar-2 guidelines [29], researchers are strongly
encouraged to list studies with reasons for exclusion when conducting systematic reviews.
Another criterion is reporting the source of funding for studies included in systematic reviews. The eligible systematic review included in this study could not meet this
criterion. This result of the research is consistent with the findings of some previous investigations [58–63]. On the other hand, the research conducted in 2020 on systematic reviews on spine surgery found that about 70% of the systematic reviews in this field could
meet these criteria [57], which is inconsistent with our results.
Besides, 60% of the outcomes was found to have low-quality evidence, meaning that
the actual effect could significantly differ from the assessed effect in the outcomes. Of the
five main factors assessed, the risk of bias was identified as the most common factor (n = 5,
100%) reducing the quality of the evidence, which suggests that researchers should pay
close attention to concealing attribution, using methods of blinding to reduce the impact
of limitations on outcome indicators. In addition, an inadequate sample size resulted in
imprecision in 80% of the outcomes, reducing the quality of the evidence. This means that
researchers should pay attention to optimal information size (OIS) [64] when conducting
meta-analyses. In addition, publication bias was found in 60% of the results, possibly due
to a failure to search comprehensively [65], as the included study did not search the grey
literature.
According to the results of the included systematic review, Fitbit had a significant
effect on increasing steps per day (MD, 950/54, CI: 475.89, 1425.18) [42]. Nevertheless, as
the data analysis of the result of the current study showed, this outcome is moderately
certain, which means that the actual effect is probably close to the estimate of the effect.
Still, it is also possible to be substantially different [66]. In addition, the results of the metaanalysis of the included systematic review [42] demonstrated the significant efficacy of
Fitbit on moderate to vigorous physical activity (MD, 6/16, CI: 2.80, 9.51). However, it
should be noted that the certainty of this evidence is low due to the result of GRADE on
this outcome. In addition, the effectiveness of Fitbit on weight difference (MD, -1/48, CI: -2.81,
-0.14) and objectively measured sedentary behavior (MD, -10/62, CI: -35.50, 14.27) was
confirmed in the included study[42], but both had low certainty. This suggests that the
actual effect may significantly differ from the effect estimates [66]. On the other hand,
Fitbit had no significant effect on self-reported sedentary behavior (SMD, -0/11, CI: -0.48,
0.26) according to the results of the included review study [42]. Because the quality assessment of this evidence using GRADE revealed moderate certainty, one can be moderately
confident in this effect estimate [66].
To answer the first hypothesis, it should be noted that the only included systematic
review had low methodological quality according to the current study results. As for the
second hypothesis, the application of the GRADE tool showed that none of the outcomes
measured by Fitbit had a high quality of evidence. Accordingly, the effect of Fitbit in increasing daily steps and improving self-reported sedentary behavior has a moderate quality of evidence. Regarding moderate to vigorous physical activity, weight difference, and
objectively measured sedentary behavior, the effect of Fitbit on the above outcomes had
low certainty.
5. Conclusions
Overall, one systematic review was included in this study, and it was classified as
being of low methodological quality by the AMSTAR-2 tool. From the GRADE classification of the results of the meta-analyses in the included SR, there were three case of lowquality evidence including moderate to vigorous physical activity, weight, and objectively
measured sedentary behavior. The other two outcomes, which included steps per day and
self-reported sedentary behaviors, had moderate-quality evidence. Regarding the results
of meta-analyses, regardless of the significance or insignificance of the effect sizes, the
degree of certainty of the evidence should be determined and considered before a decision
is made. As the current study results showed, there is moderate and low certainty about
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the effect of Fitbit on daily steps, moderate to vigorous physical activity, weight management, and sedentary behavior. Researchers in the field are encouraged to conduct more
clinical studies and meta-analyses and should continue their education and pursue the
AMSTAR-2 guidelines and GRADE to design high grade studies in the future that will
definitely affect decisions about the use of activity trackers like Fitbit.
Strength of the study
Two well-validated tools were used, namely Amstar-2, a new version of AMSTAR,
and GRADE, to assess the methodological quality as well as the quality of evidence synthesis of the literature, which enhances the quality of the research. Additionally, the search
was conducted in three of the most reliable electronic databases, namely PubMed, Scopus,
and Web of Science, and it was not restricted to a specific time period, which improved
the quality of the search. Reviewing the reference lists of the final eligible studies may also
be considered an additional aspect in determining the robustness of the search.
Limitations of the study
The findings of the current study should be evaluated in light of its limitations. To
find similar research, the keywords Fitbit, Garmin, and Apple Watch were used. The sensitivity and specificity of the search algorithm in retrieving all relevant articles were not
analyzed or verified, but these three keywords were hypothesized to be of potential use
in obtaining similar articles. Moreover, the small number of studies ultimately found may
be considered another limitation. According to the registered protocol, only one systematic review that evaluated the effectiveness of Fitbit across five distinct outcomes met the
inclusion criteria. Using the search strategy outlined above, no studies could be found that
examine the effect of Garmin or Apple Watch on health outcomes.
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